P200 - A phase I, age and gender stratified, open-label, parallel-group, single-dose study assessing pharmacokinetics (PK) of a single 4.8 g oral dose of MMX™ the mesalazine in healthy volunteers | Zendy

AI Assistant Blog Pricing

P200 - A phase I, age and gender stratified, open-label, parallel-group, single-dose study assessing pharmacokinetics (PK) of a single 4.8 g oral dose of MMX™ the mesalazine in healthy volunteers

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.